Epitopea and Merck Partner to Identify Cryptigen Tumor Antigens
UK-based RNA immunotherapy developer Epitopea announced a licensing and research cooperation agreement with US pharmaceutical...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity